Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Other Working Capital Changes (2024 - 2025)

Kairos Pharma (KAPA) has disclosed Other Working Capital Changes for 2 consecutive years, with $33000.0 as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Other Working Capital Changes rose 1750.0% year-over-year to $33000.0, compared with a TTM value of $71000.0 through Jun 2025, changed N/A, and an annual FY2024 reading of $30000.0, up 275.0% over the prior year.
  • Other Working Capital Changes was $33000.0 for Q2 2025 at Kairos Pharma, up from $17000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $33000.0 in Q2 2025 and bottomed at -$7000.0 in Q3 2024.